Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Precipio Debt to Equity Ratio 2010-2024 | PRPO

Current and historical debt to equity ratio values for Precipio (PRPO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Precipio debt/equity for the three months ending June 30, 2024 was 0.03.
  
Precipio Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-06-30 $0.01B $0.01B 0.43
2024-03-31 $0.00B $0.01B 0.30
2023-12-31 $0.00B $0.01B 0.25
2023-09-30 $0.01B $0.01B 0.47
2023-06-30 $0.01B $0.01B 0.38
2023-03-31 $0.01B $0.01B 0.37
2022-12-31 $0.01B $0.02B 0.31
2022-09-30 $0.01B $0.02B 0.29
2022-06-30 $0.01B $0.02B 0.26
2022-03-31 $0.01B $0.02B 0.26
2021-12-31 $0.01B $0.03B 0.24
2021-09-30 $0.01B $0.03B 0.22
2021-06-30 $0.01B $0.03B 0.23
2021-03-31 $0.01B $0.02B 0.40
2020-12-31 $0.01B $0.01B 0.46
2020-09-30 $0.01B $0.01B 0.50
2020-06-30 $0.01B $0.01B 0.51
2020-03-31 $0.01B $0.01B 0.68
2019-12-31 $0.01B $0.01B 0.48
2019-09-30 $0.01B $0.02B 0.47
2019-06-30 $0.01B $0.01B 0.56
2019-03-31 $0.01B $0.01B 1.20
2018-12-31 $0.02B $0.01B 2.53
2018-09-30 $0.02B $0.01B 1.69
2018-06-30 $0.01B $0.01B 1.12
2018-03-31 $0.01B $0.01B 0.95
2017-12-31 $0.01B $0.01B 1.09
2017-09-30 $0.02B $0.02B 0.71
2017-06-30 $0.02B $0.02B 0.87
2017-03-31 $0.02B $-0.02B -1.06
2016-12-31 $0.01B $-0.01B -1.13
2016-09-30 $0.02B $-0.02B -1.12
2016-06-30 $0.02B $-0.02B -1.19
2016-03-31 $0.02B $-0.02B -1.23
2015-12-31 $0.02B $-0.01B -1.38
2015-09-30 $0.02B $0.01B 2.64
2015-06-30 $0.02B $0.01B 1.88
2015-03-31 $0.02B $0.01B 2.43
2014-12-31 $0.02B $0.01B 3.58
2014-09-30 $0.02B $0.01B 2.02
2014-06-30 $0.02B $0.01B 2.00
2014-03-31 $0.02B $0.01B 1.15
2013-12-31 $0.02B $0.01B 1.65
2013-09-30 $0.02B $0.02B 1.16
2013-06-30 $0.02B $0.02B 0.87
2013-03-31 $0.02B $0.02B 0.72
2012-12-31 $0.02B $0.02B 0.91
2012-09-30 $0.02B $0.02B 0.90
2012-06-30 $0.02B $0.03B 0.76
2012-03-31 $0.02B $0.03B 0.82
2011-12-31 $0.02B $0.01B 2.04
2011-09-30 $0.03B $-0.00B -20.92
2011-06-30 $0.03B $0.00B 275.58
2011-03-31 $0.03B $0.01B 4.62
2010-12-31 $0.02B $0.01B 2.77
2010-09-30 $0.01B $0.01B 0.50
2010-06-30 $0.00B $0.01B 0.45
2010-03-31 $0.01B $0.01B 0.45
2009-12-31 $0.00B $0.01B 0.37
2009-09-30 $0.00B $0.01B 0.34
2009-06-30 $0.00B $0.01B 0.35
2009-03-31 $0.01B $0.01B 0.37
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.009B $0.015B
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $40.428B 21.75
Tempus AI (TEM) United States $7.918B 0.00
Inspire Medical Systems (INSP) United States $6.215B 1157.72
Axonics (AXNX) United States $3.513B 0.00
Hims & Hers Health (HIMS) United States $3.503B 203.88
10x Genomics (TXG) United States $2.660B 0.00
Enovis (ENOV) United States $2.437B 17.67
Azenta (AZTA) United States $2.413B 137.03
Privia Health (PRVA) United States $2.280B 158.92
IRhythm Technologies (IRTC) United States $2.219B 0.00
Omnicell (OMCL) United States $1.968B 64.82
Clover Health Investments (CLOV) United States $1.492B 0.00
Schrodinger (SDGR) United States $1.436B 0.00
Phreesia (PHR) United States $1.389B 0.00
Standard BioTools (LAB) United States $0.753B 0.00
Fulgent Genetics (FLGT) United States $0.694B 0.00
Definitive Healthcare (DH) United States $0.538B 456.00
Health Catalyst (HCAT) United States $0.529B 0.00
Butterfly Network (BFLY) United States $0.406B 0.00
Talkspace (TALK) United States $0.343B 0.00
Pulmonx (LUNG) United States $0.329B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.286B 0.00
TruBridge (TBRG) United States $0.183B 13.44
P3 Health Partners (PIII) United States $0.165B 0.00
American Well (AMWL) United States $0.147B 0.00
Augmedix (AUGX) United States $0.115B 0.00
EUDA Health Holdings (EUDA) Singapore $0.090B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
SHL Telemedicine (SHLT) Israel $0.055B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
111 (YI) China $0.051B 0.00
Zepp Health (ZEPP) China $0.049B 0.00
CareCloud (CCLD) United States $0.045B 0.00
Movano (MOVE) United States $0.036B 0.00
Outset Medical (OM) United States $0.034B 0.00
MSP Recovery (LIFW) United States $0.025B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.024B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.018B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Syra Health (SYRA) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00